Immunohistochemical detection of transforming growth factor-α, epidermal growth factor, and vascular endothelial growth factor expression in hyperstimulated rat ovary

Acta Obstetricia et Gynecologica Scandinavica

Volumn 84, Issue 9, 2005, Pages 887-893

  Ozcakir, Hasan Tayfun ^a,b   Giray, Seren Gulsen ^a   Ozbilgin, Mahmut Kemal ^a   Uyar, Yýldýz ^a   Lacin, Selman ^a   Caglar, Husnu ^a  

^a Celal Bayar Universitesi Hastanesi   (Turkey)

^b NONE   (Turkey)

Author keywords

Epidermal growth factor; Ovarian hyperstimulation; Rat; Transforming growth factor ; Vascular endothelial growth factor

Indexed keywords

EPIDERMAL GROWTH FACTOR; FOLLITROPIN; HUMAN PLACENTA LACTOGEN; SODIUM CHLORIDE; TRANSFORMING GROWTH FACTOR ALPHA; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GRANULOSA CELL; IMMUNOHISTOCHEMISTRY; LUTEAL CELL; NONHUMAN; OVARIECTOMY; OVARY; OVARY DISEASE; OVARY FOLLICLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STIMULATION; STROMA CELL;

ANIMALS; CHORIONIC GONADOTROPIN; EPIDERMAL GROWTH FACTOR; FEMALE; FOLLICLE STIMULATING HORMONE; HORMONES; IMMUNOHISTOCHEMISTRY; MODELS, ANIMAL; ORGAN SIZE; OVARIAN HYPERSTIMULATION SYNDROME; OVARY; RATS; RATS, WISTAR; TRANSFORMING GROWTH FACTOR ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 24044485080     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0001-6349.2005.00586.x     Document Type: Article

References (29)

1. Schenker JG, Weinstein D. Ovarian hyper stimulation syndrome: a current survey. Fertil Steril 1978; 30: 255-68.
2. Elchalal U, Schenker JG. The pathophysiology of ovarian hyperstimulation syndrome: views and ideas. Hum Reprod 1997; 12: 1129-37.
3. Al-Inany HG. Human albumin is effective in prevention of severe OHSS. Acta Obstet Gynecol Scand 2001; 80: 878-82.
4. Ohba T, Ujioka T, Ishikawa K, Tanaka N, Okamura H. Ovarian hyperstimulation syndrome-model rats: the manifestation and clinical implication. Mol Cell Endocrinol 2003; 202: 47-52.
5. McElhiney B, Ardill J, Caldwell C, Lloyd F, McClure N. Variations in serum vascular endothelial growth factor binding profiles and the developments of ovarian hyperstimulation syndrome. Fertil Steril 2002; 78: 286-90.
6. Hammadeh ME, Braemert B, Baltes S, Georg T, Rosenbaum P, Schmidt W. Relationship between ovarian stimulation regimen and cytokine concentration in follicular fluid and their effect on fertilization and pregnancy outcome of patients undergoing ICSI program. Am J Reprod Immunol 2000; 43: 12-20.
7. Brannstorm M, Wang L, Norman RJ. Effect of cytokines on prostaglandin production and steroidogenesis of incubated pre-ovulatory follicles of the rat. Biol Reprod 1993; 48: 165-71.
8. Adashi EY. Endocrinology of the ovary. Hum Reprod 1994; 9: 815-27.
9. Pellicer A, Albert C, Mercader A, Bonilla-Mussoles F, Remohi J, Simon C. The pathogenesis of ovarian hyperstimulation syndrome in vivo studies investigating the role of interleukin (IL)-Iβ, IL-6 and VEGF. Fertil Steril 1999; 7: 482-9.
10. Agrawal R, Tan SL, Wild S, Sladkevicius P, Engmann L, Payne N et al. Serum vascular endothelial growth factor concentrations in in-vivo fertilization cycles predict the risk of ovarian hyperstimulation syndrome. Fertil Steril 1999; 71: 287-93.
11. Abramow Y, Barak V, Nisman B, Schenker J. Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome. Fertil Steril 1997; 67: 261-5.
12. Chen CD, Wu MY, Chen HF, Chen SU, Ho HN, Yang YS. Prognostic importance of serial cytokine changes in ascites and pleural effusion in women with severe ovarian hyperstimulation syndrome. Fertil Steril 1999; 72: 286-92.
13. Kobayashi H, Okada Y, Asahina T, Gotoh J, Terao T. The kallikrein-kinin system, but not VEGF, plays a role in the increased vascular permeability associated with OHSS. J Mol Endocrinol 1998; 20: 363-74.
14. Reeka N, Berg FD, Brucker C. Presence of transforming growth factor alpha and epidermal growth factor in human ovarian tissue and follicular fluid. Hum Reprod 1998; 13: 2199-205.
15. Coffey RJ, Derynck R, Wilcox JN. Production and autoinduction of transforming growth factor in human keratinocytes. Nature 1987; 328: 817-20.
16. Mc Elhinney B, Ardill J, Caldwell C, McClure N. Preventing ovarian hyperstimulation by inhibiting the effects of vascular endothelial growth factor. J Reprod Med 2003; 48: 243-6.
17. McClure N, Healy DL, Rogers PA, Sullivan J, Beaton L, Haning RV Jr et al. Vascular endothelial growth factor as a capillary permeability factor in ovarian hyperstimulation syndrome. Lancet 1994; 344: 235-6.
18. Lee A, Burry KA, Christenson LK, Patton PE, Stouffer RL. Vascular endothelial growth factor levels in serum and follicular fluid of patients undergoing in vitro fertilization. Fertil Steril 1997; 68: 305-11.
19. Levin ER, Rosen GF, Cassidenti DL, Yee B, Meldrum D, Wisat A et al. Role of vascular endothelial cell growth factor in ovarian hyperstimulation syndrome. J Clin Invest 1998; 102: 1978-85.
20. Yarali H, Fleige-Zahradka BG, Ho Yuen B, McComb F. The ascites in the ovarian hyperstimulation syndrome does not originate from the ovary. Fertil Steril 1993; 59: 657-61.
21. Krasnow JS, Berga SL, Guzick DS, Zeleznik AJ, Yeo KT. Vascular permeability factor and vascular endothelial growth factor in ovarian hyperstimulation syndrome: a preliminary report. Fertil Steril 1996; 65: 552-5.
22. Unkila-Kallio L, Vuorela-Vepsalainen P, Tiitinen A, Halmesmaki E, Ylikorkala O. No cyclicity in serum vascular endothelial growth factor during normal menstrual cycle but significant luteal phase elevation during an in vitro fertilization program. Am J Reprod Immunol 2000; 43: 25-30.
23. Maruo T, Ladines-Liave CA, Samoto T, Matsuo H, Manalo AS, Ito H et al. Expression of epidermal growth factor and its receptor in the human ovary during follicular growth and regression. Endocrinology 1993; 132: 924-31.
24. Feng P, Knecht M, Catt K. Hormonal control of epidermal growth factor receptors by gonadotropins during granulosa cell differentiation. Endocrinology 1987; 120: 1121-6.
25. McWilliam R, Leak RE, Coutts JR. Growth factors in human ovarian follicular fluid and growth factor receptors in granulosaluteal cells. Int J Biol Markers 1995; 10: 216-20.
26. Tsafriri A, Vale W, Hsueh AJW. Effects of transforming growth factors and inhibin-related proteins on rat preovulatory graffian follicles in vitro. Endocrinology 1989; 125: 1857-62.
27. Yeh J, Lee GY, Anderson E. Presence of TGF-alpha messenger ribonucleic acid (mRNA) and absence of EGF mRNA in rat ovarian granulosa cells, and the effects of these factors on steroidogenesis in vitro. Biol Reprod 1993; 48: 1071-81.
28. Luciano AM, Pappalardo A, Ray C, Peluso JJ. EGF inhibits large granulosa cell apoptosis by stimulating progesterone synthesis and regulating the distribution of intracellular free calcium. Biol Reprod 1994; 51: 646-54.
29. Sanbuissho A, Lee GY, Anderson E. Functional and ultrastructure characteristics of two types of rat granulosa cells cultured in the presence of FSH or transforming growth factor alpha. J Reprod Fertil 1993; 98: 367-76.